• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速开发安全候选疫苗株的策略。

A Strategy for the Rapid Development of a Safe Candidate Vaccine Strain.

机构信息

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov str., 32, 119991 Moscow, Russia.

Bach Institute of Biochemistry, Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, 119071 Moscow, Russia.

出版信息

Int J Mol Sci. 2021 Oct 28;22(21):11657. doi: 10.3390/ijms222111657.

DOI:10.3390/ijms222111657
PMID:34769085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8583953/
Abstract

Approximately 1/6 of humanity is at high risk of experiencing cholera epidemics. The development of effective and safe vaccines against the primary cause of cholera, is part of the public health measures to prevent cholera epidemics. Natural nontoxigenic isolates represent a source of new genetically improved and relatively safe vaccine strains. However, the genomic engineering of wild-type strains is difficult, and these strains are genetically unstable due to their high homologous recombination activity. We comprehensively characterized two isolates using genome sequencing, bioinformatic analysis, and microscopic, physiological, and biochemical tests. Genetic constructs were Gibson assembled and electrotransformed into . Bacterial colonies were assessed using standard microbiological and immunological techniques. As a result, we created a synthetic chromoprotein-expressing reporter operon. This operon was used to improve the genome engineering approach and monitor the stability of the genetic constructs. Finally, we created a stable candidate vaccine strain bearing a deletion and expressing the β-subunit of cholera toxin. Thus, we developed a strategy for the rapid creation of genetically stable and relatively safe candidate vaccine strains. This strategy can be applied not only to but also to other important human bacterial pathogens.

摘要

约六分之一的人类面临霍乱流行的高风险。针对霍乱的主要病原体开发有效和安全的疫苗是预防霍乱流行的公共卫生措施的一部分。天然无毒力分离株代表了新型遗传改良和相对安全的疫苗株的来源。然而,野生型菌株的基因组工程较为困难,并且由于其同源重组活性高,这些菌株的遗传稳定性较差。我们使用基因组测序、生物信息学分析以及微观、生理和生化测试对两种分离株进行了全面表征。通过 Gibson 组装和电转化将遗传构建体导入到。通过标准微生物学和免疫学技术评估细菌集落。结果,我们创建了一个表达合成色蛋白的报告基因操纵子。该操纵子用于改进基因组工程方法并监测遗传构建体的稳定性。最后,我们创建了一种携带缺失并表达霍乱毒素β亚单位的稳定候选疫苗株。因此,我们开发了一种快速创建遗传稳定和相对安全的候选疫苗株的策略。该策略不仅可应用于,还可应用于其他重要的人类细菌病原体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/deb4296bdabb/ijms-22-11657-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/c20f52f6df88/ijms-22-11657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/52665625d6a9/ijms-22-11657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/be5e830c19d8/ijms-22-11657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/f5a080803223/ijms-22-11657-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/deb4296bdabb/ijms-22-11657-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/c20f52f6df88/ijms-22-11657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/52665625d6a9/ijms-22-11657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/be5e830c19d8/ijms-22-11657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/f5a080803223/ijms-22-11657-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b1/8583953/deb4296bdabb/ijms-22-11657-g005.jpg

相似文献

1
A Strategy for the Rapid Development of a Safe Candidate Vaccine Strain.快速开发安全候选疫苗株的策略。
Int J Mol Sci. 2021 Oct 28;22(21):11657. doi: 10.3390/ijms222111657.
2
Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.产生无活性霍乱毒素类似物的重组霍乱弧菌菌株的构建与特性分析
Infect Immun. 1994 Aug;62(8):3051-7. doi: 10.1128/iai.62.8.3051-3057.1994.
3
Development and validation of a detection system for wild-type Vibrio cholerae in genetically modified cholera vaccine.基因工程霍乱疫苗中野生型霍乱弧菌检测系统的建立与验证
Biologicals. 2000 Sep;28(3):149-54. doi: 10.1006/biol.2000.0252.
4
Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection.无毒力霍乱弧菌挑战株用于评估疫苗效力和推断保护机制。
mBio. 2022 Apr 26;13(2):e0053922. doi: 10.1128/mbio.00539-22. Epub 2022 Apr 7.
5
Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.构建一种积累细胞相关霍乱毒素B亚基的霍乱弧菌原型疫苗株O395-N1-E1。
Vaccine. 2008 Oct 9;26(43):5443-8. doi: 10.1016/j.vaccine.2008.05.088. Epub 2008 Jun 26.
6
Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.用于疫苗开发的霍乱弧菌基因操作:减毒活El Tor候选疫苗株的构建
Arch Med Res. 1996 Autumn;27(3):275-83.
7
Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.构建同时表达 Inaba 和 Ogawa 血清型抗原的新型霍乱弧菌疫苗株。
Vaccine. 2011 Oct 6;29(43):7505-13. doi: 10.1016/j.vaccine.2011.06.121. Epub 2011 Jul 30.
8
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.重组无毒霍乱弧菌菌株作为减毒霍乱疫苗候选株。
Nature. 1984;308(5960):655-8. doi: 10.1038/308655a0.
9
Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.表达霍乱毒素B(ctxB)抗原的鼠伤寒沙门氏菌多价疫苗对霍乱弧菌感染产生保护性免疫反应。
Vaccine. 2015 Apr 8;33(15):1880-9. doi: 10.1016/j.vaccine.2015.02.014. Epub 2015 Feb 18.
10
CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.CVD110,一种减毒的霍乱弧菌O1埃尔托型口服活疫苗菌株。
Infect Immun. 1993 Oct;61(10):4462-8. doi: 10.1128/iai.61.10.4462-4468.1993.

引用本文的文献

1
Advanced Situation with Recombinant Toxins: Diversity, Production and Application Purposes.重组毒素的现状:多样性、生产及应用目的。
Int J Mol Sci. 2023 Feb 27;24(5):4630. doi: 10.3390/ijms24054630.

本文引用的文献

1
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性:俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.
2
Identification of Spacer and Protospacer Sequence Requirements in the Vibrio cholerae Type I-E CRISPR/Cas System.鉴定霍乱弧菌 I-E 型 CRISPR/Cas 系统中的间隔区和原间隔区序列要求。
mSphere. 2020 Nov 18;5(6):e00813-20. doi: 10.1128/mSphere.00813-20.
3
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
两种配方的基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和免疫原性:来自俄罗斯的两项开放、非随机的 1/2 期研究。
Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4.
4
Current and future cholera vaccines.当前和未来的霍乱疫苗。
Vaccine. 2020 Feb 29;38 Suppl 1:A118-A126. doi: 10.1016/j.vaccine.2019.12.011. Epub 2019 Dec 24.
5
Diversity in Natural Transformation Frequencies and Regulation across Species.自然转化频率和调控的多样性在物种间的差异。
mBio. 2019 Dec 17;10(6):e02788-19. doi: 10.1128/mBio.02788-19.
6
Conversion of a -Mediated Non-toxigenic O1 Strain to a Toxigenic Strain Using Chitin-Induced Transformation.利用几丁质诱导转化将α介导的非产毒O1菌株转化为产毒菌株。
Front Microbiol. 2019 Nov 7;10:2562. doi: 10.3389/fmicb.2019.02562. eCollection 2019.
7
CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database.CARD 2020:利用综合抗生素耐药数据库进行抗生素耐药组监测。
Nucleic Acids Res. 2020 Jan 8;48(D1):D517-D525. doi: 10.1093/nar/gkz935.
8
Characterization of Extracellular Nuclease Xds.细胞外核酸酶Xds的特性分析
Front Microbiol. 2019 Sep 10;10:2057. doi: 10.3389/fmicb.2019.02057. eCollection 2019.
9
Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates.通过在分离株集合中使用抗生素耐药基因型-表型相关性来验证 AMRFinder 工具和耐药基因数据库。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00483-19. Print 2019 Nov.
10
CRISPR-Cas systems are present predominantly on mobile genetic elements in Vibrio species.CRISPR-Cas 系统主要存在于弧菌属的移动遗传元件上。
BMC Genomics. 2019 Feb 4;20(1):105. doi: 10.1186/s12864-019-5439-1.